Complications of Tumor Necrosis Factor–α Blockade in Chronic Granulomatous Disease–Related Colitis
Open Access
- 15 December 2010
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 51 (12), 1429-1434
- https://doi.org/10.1086/657308
Abstract
Background. Chronic granulomatous disease (CGD) is a genetic disorder of the phagocyte NADPH oxidase, which predisposes patients to infections and inflammatory complications, including severe colitis. Management of CGD colitis is a challenge because standard immunosuppressive therapy increases the risk of infection in already immunocompromised hosts. Methods. We report the use of infliximab in 5 patients with CGD. Results. Infliximab administration predisposed patients to severe infections with typical CGD pathogens but not mycobacteria, as reported with infliximab in other conditions. In addition to infections, infliximab administration led to successful closure of fistulae, sometimes with other untoward consequences. Infliximab-associated complications were associated with 2 deaths. Conclusions. Infliximab use in the treatment of CGD inflammatory bowel disease requires aggressive antimicrobial prophylaxis, assiduous surveillance for infection, and vigilance for untoward gastrointestinal complications. This experience suggests that infliximab therapy is effective but has untoward consequences in patients with CGD.Keywords
This publication has 37 references indexed in Scilit:
- NADPH Oxidase Limits Innate Immune Responses in the Lungs in MicePLOS ONE, 2010
- Unrelated donor and HLA‐identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long‐term outcome and growthBritish Journal of Haematology, 2009
- Crohn's disease: current treatment optionsArchives of Disease in Childhood, 2008
- Infliximab-induced disseminated histoplasmosis in a patient with Crohn's diseaseNature Clinical Practice Gastroenterology & Hepatology, 2008
- Modern management of chronic granulomatous diseaseBritish Journal of Haematology, 2008
- Pulmonary actinomycosis complicating infliximab therapy for Crohn's diseaseThorax, 2007
- Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxisGut, 2004
- Long-Term Interferon- Therapy for Patients with Chronic Granulomatous DiseaseClinical Infectious Diseases, 2004
- Maintenance of Remission in Crohn’s DiseaseDrugs, 2004
- Colitis in chronic granulomatous diseaseArchives of Disease in Childhood, 2001